Cigna Group — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2020-02-11

Reporting Person: Miller Steven B (EVP, Chief Clinical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-11	Common Stock, $.01 Par Value	M	8406.0000	$121.1371	Acquired	32071.0000	Direct
2020-02-11	Common Stock, $.01 Par Value	S	7145.0000	$212.1538	Disposed	24926.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-11	Employee Stock Option (Right to Buy)	$121.1371	M	8406.0000	Disposed	2020-03-06	Common Stock, $.01 Par Value (8406.0000)	Direct

Footnotes

F1: Represents the weighted average price of the shares sold. The prices actually received ranged from $211.546 to $212.46 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.

F2: This option was granted on March 6, 2013. The option vested in three equal annual installments on February 28, 2014, February 28, 2015 and February 28, 2016.